“Many scientists believe that this year could be a breakthrough in finding cures for cancer in DNA and investors could get familiar with terms like CRISPR and precision medicine to make the most out of advancements in this space.”
Heading into an earnings season in which many companies will be posting much lower earnings as a result of the pandemic.
“Make no mistake: These stocks are risky. Nonetheless, each of these companies has a few factors in its favor aside from being popular with retail traders, so if you’re looking for a high-risk and high-reward stock to add to your portfolio, one of these might be worth buying,”
Which biotech stocks will be the next to reward risk-tolerant investors with massive returns?
“The health care sector, some biotech stocks in particular, are looking to explode in 2021,” declares the author of today’s article, who further notes that “There have been some breakout companies as a result of the coronavirus pandemic, but other catalysts will be playing into the expected gains as well.”
Four biotech penny stocks to consider for your watch list right now.
It may be worthwhile to have a look at some of the most popular stocks on the Robinhood trading platform – especially those in the red-hot biotech space.
Biotech Start-ups poised to take off in the next 12 months.
Profitable Biotech Stocks with a high probability of putting profits in your pocket right now.
Biotech IPOs have helped drug developers raise over $5 billion so far this year.